Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

The effect of methotrexate versus other disease-modifying anti-rheumatic drugs on serum drug levels and clinical response in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors.

Martínez-Feito A, Plasencia-Rodríguez C, Navarro-Compán V, Hernández-Breijo B, González MÁ, Monjo I, Nuño L, Nozal P, Pascual-Salcedo D, Balsa A.

Clin Rheumatol. 2018 Nov 6. doi: 10.1007/s10067-018-4355-0. [Epub ahead of print]

PMID:
30402698
2.

Atlas of Axial Spondyloarthritis in Spain 2017: Study Design and Population.

Garrido-Cumbrera M, Navarro-Compán V, Zarco P, Collantes-Estévez E, Gálvez-Ruiz D, Braçe O, Chacón García J, Blanch Mur C, Costa Ferrer A, Hidalgo Vega A, Plazuelo Ramos P, Gratacós Masmitja J.

Reumatol Clin. 2018 Oct 3. pii: S1699-258X(18)30183-9. doi: 10.1016/j.reuma.2018.08.003. [Epub ahead of print] English, Spanish.

3.

Assessment of SpondyloArthritis International Society (ASAS) Consensus on Spanish Nomenclature for Spondyloarthritis.

Navarro-Compán V, Otón T, Loza E, Almodóvar R, Ariza-Ariza R, Bautista-Molano W, Burgos-Vargas R, Collantes-Estévez E, de Miguel E, González-Fernández C, Gratacós J, Ibáñez S, Juanola X, Maldonado-Cocco J, Moltó A, Mulero J, Pacheco-Tena C, Ramos-Remus C, Sanz-Sanz J, Valle-Oñate R, Zarco P, Marzo-Ortega H.

Reumatol Clin. 2018 Sep 4. pii: S1699-258X(18)30173-6. doi: 10.1016/j.reuma.2018.07.014. [Epub ahead of print] English, Spanish.

4.

Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis.

Kiltz U, van der Heijde D, Boonen A, Akkoc N, Bautista-Molano W, Burgos-Vargas R, Wei JC, Chiowchanwisawakit P, Dougados M, Duruoz MT, Elzorkany BK, Gaydukova I, Gensler LS, Gilio M, Grazio S, Gu J, Inman RD, Kim TJ, Navarro-Compan V, Marzo-Ortega H, Ozgocmen S, Pimentel Dos Santos F, Schirmer M, Stebbings S, Van den Bosch FE, van Tubergen A, Braun J.

Ann Rheum Dis. 2018 Sep;77(9):1311-1317. doi: 10.1136/annrheumdis-2017-212076. Epub 2018 Jun 1.

PMID:
29858176
5.

The EJES-3D tool for personalized prescription of exercise in axial spondyloarthritis through multimedia animations: pilot study.

Flórez MT, Almodóvar R, García Pérez F, Rodríguez Cambrón AB, Carmona L, Pérez Manzanero MÁ, Aboitiz Cantalapiedra J, Urruticoechea-Arana A, Rodríguez Lozano CJ, Castro C, Fernández-Carballido C, de Miguel E, Galíndez E, Álvarez Vega JL, Torre Alonso JC, Linares LF, Moreno M, Navarro-Compán V, Juanola X, Zarco P.

Rheumatol Int. 2018 Jul;38(7):1277-1284. doi: 10.1007/s00296-018-4049-6. Epub 2018 May 21.

PMID:
29786781
6.

Prevalence and characteristics associated with dactylitis in patients with early spondyloarthritis: results from the ESPeranza cohort.

Tévar-Sánchez MI, Navarro-Compán V, Aznar JJ, Linares LF, Castro MC, De Miguel E; ESPERANZA Group.

Clin Exp Rheumatol. 2018 Sep-Oct;36(5):879-883. Epub 2018 May 8.

7.

Should over-treatment of axial spondyloarthritis with biologics remain a concern after the issue of the new ASAS criteria? Data from REGISPONSERBIO (Spanish Register of Biological Therapy in Spondyloarthritides).

Moreno M, Gratacós J, Navarro-Compán V, de Miguel E, Font P, Clavaguera T, Linares LF, Joven B, Juanola X; and the Regisponserbio group.

Clin Exp Rheumatol. 2018 May 8. [Epub ahead of print]

PMID:
29745878
8.

Golimumab Tapering Strategy Based on Serum Drug Levels in Patients With Spondyloarthritis.

Redondo C, Martínez-Feito A, Plasencia-Rodríguez C, Navarro-Compán V, Nuño-Nuño L, Peiteado D, Villalba A, Jochems A, Pascual-Salcedo D, Balsa A.

Arthritis Rheumatol. 2018 Aug;70(8):1356-1358. doi: 10.1002/art.40542. Epub 2018 Jul 2. No abstract available.

PMID:
29736972
9.

Switching biological disease-modifying antirheumatic drugs in patients with axial spondyloarthritis: results from a systematic literature review.

Navarro-Compán V, Plasencia-Rodríguez C, de Miguel E, Diaz Del Campo P, Balsa A, Gratacós J.

RMD Open. 2017 Oct 10;3(2):e000524. doi: 10.1136/rmdopen-2017-000524. eCollection 2017.

10.

Recommendations by the Spanish Society of Rheumatology on the Use of Biological Therapies in Axial Spondyloarthritis.

Gratacós J, Díaz Del Campo Fontecha P, Fernández-Carballido C, Juanola Roura X, Linares Ferrando LF, de Miguel Mendieta E, Muñoz Fernández S, Rosales-Alexander JL, Zarco Montejo P, Guerra Rodríguez M, Navarro Compán V.

Reumatol Clin. 2017 Oct 16. pii: S1699-258X(17)30232-2. doi: 10.1016/j.reuma.2017.08.008. [Epub ahead of print] English, Spanish.

11.

Optimal concentration range of golimumab in patients with axial spondyloarthritis.

Martínez-Feito A, Plasencia-Rodriguez C, Navarro-Compán V, Jurado T, Kneepkens EL, Wolbink GJ, Martín S, Ruiz Del Agua A, Navarro R, Mezcua A, Jochems A, Peiteado D, Bonilla MG, Balsa A, Pascual-Salcedo D.

Clin Exp Rheumatol. 2018 Jan-Feb;36(1):110-114. Epub 2017 Sep 15.

PMID:
28980904
12.

Sacroiliac radiographic progression in recent onset axial spondyloarthritis: the 5-year data of the DESIR cohort.

Dougados M, Sepriano A, Molto A, van Lunteren M, Ramiro S, de Hooge M, van den Berg R, Navarro Compan V, Demattei C, Landewé R, van der Heijde D.

Ann Rheum Dis. 2017 Nov;76(11):1823-1828. doi: 10.1136/annrheumdis-2017-211596. Epub 2017 Jul 6.

13.

Development of a checklist for patients with axial spondyloarthritis and psoriatic arthritis in daily practice: ONLY TOOLS project.

Almodovar R, Torre Alonso JC, Batlle E, Castillo C, Collantes-Estevez E, de Miguel E, González S, Gratacós J, Hernández A, Juanola X, Linares LF, Moreno MJ, Moreno M, Navarro-Compán V, Rodríguez Lozano C, Sanz J, Sellas A, Loza E, Zarco P; grupo de trabajo ONLY TOOLS.

Reumatol Clin. 2018 May - Jun;14(3):155-159. doi: 10.1016/j.reuma.2016.12.003. Epub 2017 Mar 9. English, Spanish.

14.

Recommendations for the Use of Ultrasound and Magnetic Resonance in Patients With Spondyloarthritis, Including Psoriatic Arthritis, and Patients With Juvenile Idiopathic Arthritis.

Uson J, Loza E, Möller I, Acebes C, Andreu JL, Batlle E, Bueno Á, Collado P, Fernández-Gallardo JM, González C, Jiménez Palop M, Lisbona MP, Macarrón P, Maymó J, Narváez JA, Navarro-Compán V, Sanz J, Rosario MP, Vicente E, Naredo E.

Reumatol Clin. 2018 Jan - Feb;14(1):27-35. doi: 10.1016/j.reuma.2016.08.008. Epub 2016 Oct 27. English, Spanish.

15.

In patients with axial spondyloarthritis, inflammation on MRI of the spine is longitudinally related to disease activity only in men: 2 years of the axial spondyloarthritis DESIR cohort.

Navarro-Compán V, Ramiro S, Landewé R, Dougados M, Miceli-Richard C, Richette P, van der Heijde D.

Ann Rheum Dis. 2018 Mar;77(3):470-472. doi: 10.1136/annrheumdis-2016-210697. Epub 2017 Mar 3. No abstract available.

PMID:
28258059
16.

Diagnostic Value and Validity of Early Spondyloarthritis Features: Results From a National Spanish Cohort.

Joven BE, Navarro-Compán V, Rosas J, Fernandez Dapica P, Zarco P, de Miguel E; Esperanza Working Group.

Arthritis Care Res (Hoboken). 2017 Jun;69(6):938-942. doi: 10.1002/acr.23017. Epub 2017 May 9.

17.

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.

van der Heijde D, Ramiro S, Landewé R, Baraliakos X, Van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M, van Gaalen F, Géher P, van der Horst-Bruinsma I, Inman RD, Jongkees M, Kiltz U, Kvien TK, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compàn V, Ozgocmen S, Pimentel-Santos FM, Reveille J, Rudwaleit M, Sieper J, Sampaio-Barros P, Wiek D, Braun J.

Ann Rheum Dis. 2017 Jun;76(6):978-991. doi: 10.1136/annrheumdis-2016-210770. Epub 2017 Jan 13. Review.

PMID:
28087505
18.

Recommendations for the use of ultrasound and magnetic resonance in patients with rheumatoid arthritis.

Möller I, Loza E, Uson J, Acebes C, Andreu JL, Batlle E, Bueno Á, Collado P, Fernández-Gallardo JM, González C, Jiménez Palop M, Lisbona MP, Macarrón P, Maymó J, Narváez JA, Navarro-Compán V, Sanz J, Rosario MP, Vicente E, Naredo E.

Reumatol Clin. 2018 Jan - Feb;14(1):9-19. doi: 10.1016/j.reuma.2016.08.010. Epub 2016 Oct 29. English, Spanish.

19.

Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages.

Kiltz U, van der Heijde D, Boonen A, Bautista-Molano W, Burgos-Vargas R, Chiowchanwisawakit P, Duruoz T, El-Zorkany B, Essers I, Gaydukova I, Géher P, Gossec L, Grazio S, Gu J, Khan MA, Kim TJ, Maksymowych WP, Marzo-Ortega H, Navarro-Compán V, Olivieri I, Patrikos D, Pimentel-Santos FM, Schirmer M, van den Bosch F, Weber U, Zochling J, Braun J.

RMD Open. 2016 Oct 4;2(2):e000311. eCollection 2016.

20.

Differences between familial and sporadic early spondyloarthritis: results from the ESPERANZA cohort.

Almodóvar R, Navarro-Compán V, Fernández-Carballido C, Hernández A, De Miguel E, Zarco P; ESPERANZA Study Group.

Clin Exp Rheumatol. 2016 Jul-Aug;34(4):575-80. Epub 2016 Jun 22.

PMID:
27384500

Supplemental Content

Loading ...
Support Center